Media

• E-Commerce
• Investing
• Marketing and Advertising
• News and Media
• Business Services

Popular tags

• the
• to
• market
• united
• states
• united states
• states united
• llp
• announces
• global
• of
• stock
• earnings
• business
• stocks
• in
• call
• report
• data
• results

Keywords

2025-06-04 08:44:16| The Economic Times

Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and atopic dermatitis. The company has decided to discontinue development of the drug. Separately, a surprise FDA inspection is underway at Sun Pharmas Halol manufacturing facility.

Category: News and Media

Latest from this category

13.12 F&O Talk | Nifty corrects 2.5% after record high; All eyes now on this key breakout level: Sudeep Shah 13.12 ICICI Direct names Bajaj Finserv, IOL among 7 top picks as it sees Nifty at 30,000 in 2026 13.12 Where valuations still make sense: ICICI Pru's Vaibhav Dusad on IT, banks and select contrarian bets 13.12 Heads I win, tails you lose: Rich Dad Poor Dad author Robert Kiyosaki warns on global banking, advocates gold, silver, Bitcoin 13.12 Eternal and Temasek-backed Shiprocket files updated DRHP for Rs 2,342 crore IPO 13.12 Bitcoin slips over 2% in one day after AI, Tech stocks slide on weak US earnings; crypto monthly decline extends to 10% 13.12 Christmas gifts wrapped and sent out for children 13.12 Ramco Systems among top 6 unique stocks held by mutual funds in November News and Media »

All news

13.12 AI advertising slop is on the rise. The cure? The STFU brand strategy 13.12 90 housing markets cross critical inventory thresholdtilting power toward buyers 13.12 The 3 key financial lessons of Its a Wonderful Life 13.12 CNBC replaces its peacock with . . . a triangle 13.12 F&O Talk | Nifty corrects 2.5% after record high; All eyes now on this key breakout level: Sudeep Shah 13.12 ICICI Direct names Bajaj Finserv, IOL among 7 top picks as it sees Nifty at 30,000 in 2026 13.12 Where valuations still make sense: ICICI Pru's Vaibhav Dusad on IT, banks and select contrarian bets 13.12 Heads I win, tails you lose: Rich Dad Poor Dad author Robert Kiyosaki warns on global banking, advocates gold, silver, Bitcoin More »